Cargando…

Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001

The 5th year KONSAR surveillance in 2001 was based on routine test data at 30 participating hospitals. It was of particular interest to find a trend in the resistances of enterococci to vancomycin, of Enterobacteriaceae to the 3rd generation cephalosporin and fluoroquinolone, and of Pseudomonas aeru...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyungwon, Jang, Sook-Jin, Lee, Hee Joo, Ryoo, Namhee, Kim, Myungshin, Hong, Seong Geun, Chong, Yunsop
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822269/
https://www.ncbi.nlm.nih.gov/pubmed/14966334
http://dx.doi.org/10.3346/jkms.2004.19.1.8
_version_ 1782177513617752064
author Lee, Kyungwon
Jang, Sook-Jin
Lee, Hee Joo
Ryoo, Namhee
Kim, Myungshin
Hong, Seong Geun
Chong, Yunsop
author_facet Lee, Kyungwon
Jang, Sook-Jin
Lee, Hee Joo
Ryoo, Namhee
Kim, Myungshin
Hong, Seong Geun
Chong, Yunsop
author_sort Lee, Kyungwon
collection PubMed
description The 5th year KONSAR surveillance in 2001 was based on routine test data at 30 participating hospitals. It was of particular interest to find a trend in the resistances of enterococci to vancomycin, of Enterobacteriaceae to the 3rd generation cephalosporin and fluoroquinolone, and of Pseudomonas aeruginosa and acinetobacters to carbapenem. Resistance rates of Gram-positive cocci were: 70% of Staphylococcus aureus to oxacillin; 88% and 16% of Enterococcus faecium to ampicillin and vancomycin, respectively. Seventy-two percent of pneumococci were nonsusceptible to penicillin. The resistance rates of Enterobacteriaceae were: Escherichia coli, 28% to fluoroquinolone; Klebsiella pneumoniae, 27% to ceftazidime, and 20% to cefoxitin; and Enterobacter cloacae, ≥40% to cefotaxime and ceftazidime. The resistance rates of P. aeruginosa were 21% to ceftazidime, 17% to imipenem, and those of the acinetobacters were ≥61% to ceftazidime, aminoglycosides, fluoroquinolone and cotrimoxazole. Thirty-five percent of non-typhoidal salmonellae were ampicillin resistant, and 66% of Haemophilus influenzae were β-lactamase producers. Notable changes over the 1997-2001 period were: increases in vancomycin-resistant E. faecium, and amikacin- and fluoroquinolone-resistant acinetobacters. With the increasing prevalence of resistant bacteria, nationwide surveillance has become more important for optimal patient management, for the control of nosocomial infection, and for the conservation of the newer antimicrobial agents.
format Text
id pubmed-2822269
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-28222692010-02-16 Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001 Lee, Kyungwon Jang, Sook-Jin Lee, Hee Joo Ryoo, Namhee Kim, Myungshin Hong, Seong Geun Chong, Yunsop J Korean Med Sci Original Article The 5th year KONSAR surveillance in 2001 was based on routine test data at 30 participating hospitals. It was of particular interest to find a trend in the resistances of enterococci to vancomycin, of Enterobacteriaceae to the 3rd generation cephalosporin and fluoroquinolone, and of Pseudomonas aeruginosa and acinetobacters to carbapenem. Resistance rates of Gram-positive cocci were: 70% of Staphylococcus aureus to oxacillin; 88% and 16% of Enterococcus faecium to ampicillin and vancomycin, respectively. Seventy-two percent of pneumococci were nonsusceptible to penicillin. The resistance rates of Enterobacteriaceae were: Escherichia coli, 28% to fluoroquinolone; Klebsiella pneumoniae, 27% to ceftazidime, and 20% to cefoxitin; and Enterobacter cloacae, ≥40% to cefotaxime and ceftazidime. The resistance rates of P. aeruginosa were 21% to ceftazidime, 17% to imipenem, and those of the acinetobacters were ≥61% to ceftazidime, aminoglycosides, fluoroquinolone and cotrimoxazole. Thirty-five percent of non-typhoidal salmonellae were ampicillin resistant, and 66% of Haemophilus influenzae were β-lactamase producers. Notable changes over the 1997-2001 period were: increases in vancomycin-resistant E. faecium, and amikacin- and fluoroquinolone-resistant acinetobacters. With the increasing prevalence of resistant bacteria, nationwide surveillance has become more important for optimal patient management, for the control of nosocomial infection, and for the conservation of the newer antimicrobial agents. The Korean Academy of Medical Sciences 2004-02 2004-02-28 /pmc/articles/PMC2822269/ /pubmed/14966334 http://dx.doi.org/10.3346/jkms.2004.19.1.8 Text en Copyright © 2004 The Korean Academy of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Kyungwon
Jang, Sook-Jin
Lee, Hee Joo
Ryoo, Namhee
Kim, Myungshin
Hong, Seong Geun
Chong, Yunsop
Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001
title Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001
title_full Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001
title_fullStr Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001
title_full_unstemmed Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001
title_short Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea: KONSAR Study in 2001
title_sort increasing prevalence of vancomycin-resistant enterococcus faecium, expanded-spectrum cephalosporin-resistant klebsiella pneumoniae, and imipenem-resistant pseudomonas aeruginosa in korea: konsar study in 2001
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822269/
https://www.ncbi.nlm.nih.gov/pubmed/14966334
http://dx.doi.org/10.3346/jkms.2004.19.1.8
work_keys_str_mv AT leekyungwon increasingprevalenceofvancomycinresistantenterococcusfaeciumexpandedspectrumcephalosporinresistantklebsiellapneumoniaeandimipenemresistantpseudomonasaeruginosainkoreakonsarstudyin2001
AT jangsookjin increasingprevalenceofvancomycinresistantenterococcusfaeciumexpandedspectrumcephalosporinresistantklebsiellapneumoniaeandimipenemresistantpseudomonasaeruginosainkoreakonsarstudyin2001
AT leeheejoo increasingprevalenceofvancomycinresistantenterococcusfaeciumexpandedspectrumcephalosporinresistantklebsiellapneumoniaeandimipenemresistantpseudomonasaeruginosainkoreakonsarstudyin2001
AT ryoonamhee increasingprevalenceofvancomycinresistantenterococcusfaeciumexpandedspectrumcephalosporinresistantklebsiellapneumoniaeandimipenemresistantpseudomonasaeruginosainkoreakonsarstudyin2001
AT kimmyungshin increasingprevalenceofvancomycinresistantenterococcusfaeciumexpandedspectrumcephalosporinresistantklebsiellapneumoniaeandimipenemresistantpseudomonasaeruginosainkoreakonsarstudyin2001
AT hongseonggeun increasingprevalenceofvancomycinresistantenterococcusfaeciumexpandedspectrumcephalosporinresistantklebsiellapneumoniaeandimipenemresistantpseudomonasaeruginosainkoreakonsarstudyin2001
AT chongyunsop increasingprevalenceofvancomycinresistantenterococcusfaeciumexpandedspectrumcephalosporinresistantklebsiellapneumoniaeandimipenemresistantpseudomonasaeruginosainkoreakonsarstudyin2001
AT increasingprevalenceofvancomycinresistantenterococcusfaeciumexpandedspectrumcephalosporinresistantklebsiellapneumoniaeandimipenemresistantpseudomonasaeruginosainkoreakonsarstudyin2001